Related Experiment Video
Updated: Jun 11, 2026

08:57
Amplicon Sequencing using the Long-Read Sequencing Technologies
Published on: August 29, 2025
Research overview-2025: integrating scientific progress to accelerate global tuberculosis elimination.
Patrick K Moonan1, Timothy H Holtz2
1U.S. Centers for Disease Control and Prevention, Division of Global HIV and Tuberculosis, Atlanta, GA, United States.
Frontiers in Tuberculosis
|June 10, 2026
Summary
Scientific advances in 2025 accelerated tuberculosis elimination efforts. Innovations in diagnostics, treatments, and prevention offer new tools, but equitable access remains crucial for global impact.
Area of Science:
- Tuberculosis research
- Infectious disease elimination
- Global health
Background:
- Tuberculosis remains a major global health challenge.
- Progress toward global elimination requires continuous innovation.
- 2025 saw significant scientific breakthroughs across the tuberculosis research spectrum.
Purpose of the Study:
- To review and synthesize major scientific advances in tuberculosis research from 2025.
- To highlight innovations in diagnosis, treatment, prevention, and post-disease care.
- To assess the potential impact of these advances on global tuberculosis elimination.
Main Methods:
- Comprehensive review of scientific literature and research developments in 2025.
- Synthesis of findings across diagnostic, therapeutic, and preventive domains.
- Analysis of conceptual advancements and health system considerations.
Main Results:
- Diagnostic innovations include AI-enabled imaging, noninvasive molecular tests, and point-of-care methods.
- Therapeutic progress features shorter all-oral regimens and novel drug compounds.
- Advances in host-directed therapies, vaccines, and drug delivery systems were noted.
- New definitions for post-tuberculosis lung disease clarify long-term patient burden.
Conclusions:
- Substantial scientific progress in 2025 provides a clearer path toward tuberculosis elimination.
- Innovations offer expanded access, mechanistic insights, and actionable tools.
- Effective implementation and integration into routine care are essential for realizing impact.
- Health system limitations and access inequities must be addressed to maximize benefits.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
